نتایج جستجو برای: Myeloproliferative neoplasm

تعداد نتایج: 188264  

Journal: :Journal of Hematopathology 2021

Myeloid/lymphoid neoplasms with FGFR1 rearrangement (MLN-FGFR1) comprise a heterogeneous group of that can present as myeloproliferative neoplasm, myelodysplastic/myeloproliferative acute myeloid leukemia, T or B lymphoblastic leukemia/lymphoma, mixed phenotype leukemia. The overall outcome these is poor, and patients often show cytogenetic evolution gain additional chromosomal abnormalities le...

Journal: :Haematologica 2012
Susanne Schnittger Ulrike Bacher Christiane Eder Frank Dicker Tamara Alpermann Vera Grossmann Alexander Kohlmann Wolfgang Kern Claudia Haferlach Torsten Haferlach

We investigated 15,542 patients with suspected BCR-ABL1- negative myeloproliferative or myelodysplastic/myeloproliferative neoplasm (including 359 chronic myelomonocytic leukemia) by a molecular marker set. JAK2V617F was detected in the suspected categories as follows: polycythemia vera 88.3%, primary myelofibrosis 53.8%, essential thrombocythemia 50.2%, and not further classifiable myeloprolif...

Journal: :Haematologica 2014
Camilla Nielsen Stig E Bojesen Børge G Nordestgaard Klaus F Kofoed Henrik S Birgens

Clinical significance of the JAK2V617F mutation in patients with a myeloproliferative neoplasm has been the target of intensive research in recent years. However, there is considerably uncertainty about prognosis in JAK2V617F positive individuals without overt signs of myeloproliferative disease. In this study, we tested the hypothesis that increased JAK2V617F somatic mutation burden is associa...

Journal: :Haematologica 2010
Sigurdur Y Kristinsson Ola Landgren Jan Samuelsson Magnus Björkholm Lynn R Goldin

The causes of myeloproliferative neoplasm (MPN) are unknown. We conducted a large population-based study including 11,039 myeloproliferative neoplasm patients and 43,550 matched controls with the aim of assessing the associations between a personal history of a broad span of autoimmune diseases and subsequent risk of myeloproliferative neoplasm. We found a prior history of any autoimmune diseas...

Journal: :Leukemia research 2012
C Michael Jones

KEY WORDS: Imatinib mesylate Polycythemia Vera Myeloproliferative disorder Myeloproliferative neoplasm Tyrosine kinase inhibitor Myelosuppressive therapy

Journal: :Hematology/Oncology Clinics of North America 2012

Journal: :Haematologica 2011
Elisa Rumi Francesco Passamonti Chiara Elena Daniela Pietra Luca Arcaini Cesare Astori Silvia Zibellini Emanuela Boveri Cristiana Pascutto Mario Lazzarino

Within a cohort of 1,915 consecutive patients with myeloproliferative neoplasm followed for a median time of 5.2 years (range 0-33.3), we investigated the occurrence of lymphoid neoplasm with the aim of defining this risk and to investigate the role of genetic predisposing factors. We identified 22 patients with myeloproliferative neoplasm who developed lymphoid neoplasm over their lifetime. We...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید